Fragile X syndrome
Fragile X syndrome Classification and external resources
Location of FMR1 gene
ICD-10 Q99.2 ICD-9 759.83 OMIM 300624 DiseasesDB 4973 eMedicine ped/800 MeSH D005600
Fragile X syndrome (FXS), Martin–Bell syndrome, or Escalante's syndrome (more commonly used in South American countries), is a genetic syndrome that is the most commonly known single-gene cause of autism and the most common inherited cause of intellectual disability. It results in a spectrum of characteristic physical and intellectual limitations and emotional and behavioral features which range from severe to mild in manifestation.
The syndrome is associated with the expansion of a single trinucleotide gene sequence (CGG) on the X-chromosome, and results in a failure to express the protein coded by the FMR1 gene, which is required for normal neural development. There are four generally accepted states of the chromosome region involved in Fragile X syndrome which relate to the length of the repeated CGG sequence; Normal (29–31 CGG repeats) (not affected by the syndrome), Premutation (55–200 CGG repeats)(not affected by the syndrome), Full Mutation (more than 200 CGG repeats)(affected), and Intermediate or Gray Zone Alleles (40–60 repeats).
J. Purdon Martin and Julia Bell in 1943, described a pedigree of X-linked mental disability, without considering the macroorchidism (larger testicles). In 1969 Herbert Lubs first sighted an unusual "marker X chromosome" in association with mental disability. In 1970 Frederick Hecht coined the term "fragile site".
Renpenning's syndrome is not synonymous with the syndrome. In Renpenning's syndrome, there is no fragile site on the X-chromosome. Renpenning's cases have short stature, moderate microcephaly, and neurological (brain) disorders.
- 1 Signs and symptoms
- 2 Diagnosis
- 3 Autism and Fragile X syndrome
- 4 Causes
- 5 Transmission
- 6 Treatment
- 7 Research
- 8 References
- 9 External links
Signs and symptoms
Aside from intellectual disability, prominent characteristics of the syndrome include an elongated face, large or protruding ears, flat feet, larger testes (macroorchidism), and low muscle tone. Speech may include cluttered speech or nervous speech. Behavioral characteristics may include stereotypic movements (e.g., hand-flapping) and atypical social development, particularly shyness, limited eye contact, memory problems, and difficulty with face encoding.
Some individuals with the fragile X syndrome also meet the diagnostic criteria for autism. Most females who have the syndrome experience symptoms to a lesser degree because of their second X-chromosome; however, they can develop symptoms just as severe as their male counterparts. While full mutation males tend to present with severe intellectual disability, the symptoms of full mutation females run the gamut of minimally affected to severe intellectual disability, which may explain why females are underdiagnosed relative to males.
In short, similarities between X-linked recessive inheritance and fragile X are:
- Males are predominantly affected;
- Females (mothers) are obligatory carriers (i.e., are conclusively proven to be carriers) if a male child is affected, but not necessarily if female children are affected, as a female child with one fragile and one normal X-chromosome may have inherited the fragile chromosome from the father.
- Prominent ears (one or both)
- Long face (vertical maxillary excess)
- High-arched palate (related to the above)
- Hyperextensible finger joints
- Double-jointed thumbs
- Flat feet
- soft skin
- Larger testes in men after puberty (postpubescent macroorchidism)
- Low muscle tone
FXS is characterized by social anxiety, including gaze aversion, prolonged time to commence social interaction, and challenges forming peer relationships. Social anxiety in individuals with FXS is related to challenges with face encoding. Face encoding is the ability to recognize a face that one has seen before.
Individuals with FXS show decreased activation in the prefrontal regions of the brain. These regions are associated with social cognition. A child with FXS is likely to have hyperactivity, anxiety, and social deficits. Individuals with fragile X-associated tremor/ataxia syndrome (FXTAS) are likely to experience dementia, mood and/or anxiety disorders. Males with the FMR1 premutation and clinical evidence of FXTAS were found to have increased occurrence of somatization, obsessive–compulsive disorder, interpersonal sensitivity, depression, phobic anxiety and psychoticism.
Females with FXS show a high frequency of avoidant behavior, mood disorder, and habit disorder. Females are significantly more withdrawn and depressed as compared to normal individuals. The size of DNA insertion was related to IQ, severity of attention problems, and withdrawal symptoms. Females with FXS are most vulnerable to social anxiety, social avoidance, withdrawal, and depression, so special attention should be paid.
Mental age is positively correlated and autistic behavior is negatively correlated with sadness in a particular study. The results shows that there are different behavioral profiles for young children than there are for older aged children which implies that temperament and problem behaviors are not rooted in early temperament.
From their 40s onward, males with FXS begin developing progressively more severe problems in performing tasks that require the central executive of working memory. Working memory involves the temporary storage of information 'in mind', while processing the same or other information. Phonological memory (or verbal working memory) deteriorates with age in males, while visual-spatial memory is not found to be directly related to age. Males often experience an impairment in the functioning of the phonological loop. The CGG length is significantly correlated with central executive and the visual–spatial memory through regression analysis. However, in a premutation individual, CGG length is only significantly correlated with the central executive, not with either phonological memory or visual–spatial memory.
Current evidence shows that individuals with premutation have difficulties with mathematics, anxiety, attention, and/or executive functions. Premutation is the stage where the CGG sequence in the FMR-1 gene expands to contain between 54 and 230 repeats. There is also a decrease in measures of executive cognitive functioning, working memory and information processing speed. The relative weaknesses observed in performance IQ can be partly attributed to slowed motor performance as a result of intention tremor. Children with FXS have an intellectual learning rate which is 2.2 times slower than unaffected children.
There is overlap of behavioral and clinical symptomology between autism and FXS. The commonalities include social and communication skills, though the degree to which these two syndromes share the processes and stages of development and medical causes for the disease (etiology) is not known. Research has shown that phenotype ‘commonalities’ reflected different developmental pathways that diverge over time and across syndromes.
Using this information will permit early and specialized interventions. These earlier interventions will allow for optimal development and show educational, clinical, and adaptive benefits in the patient. When both autism and FXS are present a severe language deficit and lower IQ is observed as compared to children with only FXS.
Hypersensitivity and repetitive behavior
Children with fragile X have very short attention spans, are hyperactive, and show hypersensitivity to visual, auditory, tactile, and olfactory stimuli. These children have difficulty in large crowds due to the loud noises and this can lead to tantrums due to hyperarousal. Children with FXS pull away from light touch and can find textures of materials to be irritating. Transitions from one location to another can be difficult for children with FXS. Behavioral therapy can be used to decrease the child’s sensitivity in some cases.
Perseveration is a common communicative and behavioral characteristic in FXS. Children with FXS may repeat a certain ordinary activity over and over. In speech, the trend is not only in repeating the same phrase but also talking about the same subject continually. Cluttered speech and self-talk are commonly seen. Self-talk includes talking with oneself using different tones and pitches.
Eye problems have not been found to develop in accordance with mental age in individuals with fragile X. But patients with the syndrome have showed delayed voluntary orienting. The group differences in reflexive orienting between individuals with Down and fragile X syndrome at the low mental age level reinforce the practice of separating etiologies and highlight the contribution of basic attentional processes in the study of people with mental limitations.
Ophthalmologic problems include strabismus (lazy eye). This requires early identification to avoid amblyopia. Surgery and/or patching are usually necessary to treat strabismus if diagnosed early. Refractive errors in patients with fragile X are also common.
According to a study of patients with fragile X premutation undergoing preimplantation genetic diagnosis (PGD), there is a positive correlation between number of CGG repeats and estradiol level, retrieved oocytes and two-pronuclear zygotes. Premutation carriers with <100 CGG repeats suffer from impaired ovarian response and decreased fertilization rate.
Fragile X syndrome was originally diagnosed by culturing cells in a folate deficient medium and then assessing the cultures for X-chromosome "breakage" by cytogenetic analysis of the long arm of the X-chromosome (the appearance of a broken chromosome being caused by discontinuity of staining in the region of the trinucleotide repeat). This technique proved unreliable for both diagnosis and carrier testing.
The fragile X abnormality is now directly determined by analysis of the number of CGG repeats and their methylation status using restriction endonuclease digestion and Southern blot analysis.
Not everyone with fragile X syndrome has the same signs and symptoms. Even affected people in the same family don’t show the same symptoms. The signs and symptoms fall into six categories:
- Intelligence and learning
- Social and emotional
- Speech and language
- Disorders commonly associated or sharing features with Fragile X
Autism and Fragile X syndrome
Fragile X syndrome can cause a child to have autism or an Autism Spectrum Disorder (ASD) though not all children with fragile X syndrome have autism or an ASD.
For 2% to 6% of all children diagnosed with autism, the cause is the Fragile X gene mutation. Approximately one-third of all children diagnosed with fragile X syndrome also have some degree of autism. Fragile X syndrome is the most common known single gene cause of autism.
From Dr. Randi Hagerman's statement to the United States House of Representatives Subcommittee on Health and Environment: "...Fragile X represents a portal through which we hope to view and treat a wide variety of other disorders of brain development and function. All children with autism...should be tested for Fragile X."
Fragile X syndrome is a genetic disorder caused by mutation of the FMR1 gene on the X-chromosome. Mutation at that site is found in 1 out of about every 2000 males and 1 out of about every 259 females. (Incidence of the disorder itself is about 1 in every 3600 males and 1 in 4000–6000 females.)
Normally, the FMR1 gene contains between 6–55 (29 in Robbins–Kumar pathology textbooks) repeats of the CGG codon (trinucleotide repeats). In people with the fragile X syndrome, the FMR1 allele has over 230–4000 repeats of this codon.
This methylation of the FMR1 locus in chromosome band Xq27.3 is believed to result in constriction of the X chromosome which appears 'fragile' under the microscope at that point, a phenomenon that gave the syndrome its name.
Mutation of the FMR1 gene leads to the transcriptional silencing of the fragile X-mental retardation protein, FMRP. In normal individuals, FMRP is believed to regulate a substantial population of mRNA: FMRP plays important roles in learning and memory, and also appears to be involved in development of axons, formation of synapses, and the wiring and development of neural circuits.
Because males normally have only one copy of the X-chromosome, those males with significant trinucleotide expansion at the FMR1 locus are symptomatic. They are intellectually disabled and may show various physical features of the fragile X syndrome.
Females have two X-chromosomes and thus have an increased probability of having a working FMR1 allele. Females carrying one X-chromosome with an expanded FMR1 gene can have some signs and symptoms of the disorder or be normal. Although the extra X-chromosome can serve as a backup, only one X-chromosome is active in each cell due to X-inactivation.
Males with the fragile X cannot transmit it to any of their sons (since males contribute a Y-chromosome, not an X, to their male offspring), but will transmit the premutation to all of their daughters, as males contribute their X to all of their daughters. Males never transmit their full mutation (males with full mutations in their blood have premutations in their sperm), and expansion to full mutations never occurs through paternal transmission.
Females carrying one copy of the fragile X can transmit it to their sons or daughters; in this case each child has a 50% chance of inheriting the fragile X. Sons who receive the fragile X are at high risk of intellectual disability. Daughters who receive the fragile X may appear normal or they may be intellectually disabled, usually to a lesser degree than boys with the syndrome. The transmission of fragile X often increases with each passing generation. This seemingly anomalous pattern of inheritance is referred to as the Sherman paradox.
Although several medications have been proposed to treat fragile X syndrome, none of them are supported by good evidence. While there is no current cure for the syndrome, there is hope that further understanding of its underlying causes would lead to new therapies. Currently, the syndrome can be treated through behavioral therapy, special education, and when necessary, treatment of physical abnormalities. Persons with the fragile X syndrome in their family histories are advised to seek genetic counseling to assess the likelihood of having children who are affected, and how severe any impairments may be in affected descendants.
Recent studies have focused on a number of critical areas. The role of FMRP's RNA partners, many of which have now been validated through in vitro assays, is of primary importance. Also being examined is the function the various domains of FMRP, an RNA-binding protein, which is still relatively unknown. One hypothesis is that many symptoms are caused by unchecked activation of mGluR5, a metabotropic glutamate receptor, which was found in a 2007 study to contribute significantly to the pathogenesis of the disease; this suggests that mGluR5 blockers could be used to treat fragile X syndrome.
- ^ http://www.fragilex.org/html/autism.htm
- ^ http://www.fragilex.org/html/summary.htm
- ^ Sherman, S. (2002). "Epidemiology". In Hagerman, R. J.; Hagerman, P. J.. Fragile X Syndrome, Diagnosis Treatment and Research (3rd ed.). Baltimore: Johns Hopkins University Press. ISBN 0801868432.
- ^ Martin, J. P. & Bell, J. (1943). "A pedigree of mental defect showing sex-linkage". J. Neurol. Psychiat. 6 (3–4): 154–157. doi:10.1136/jnnp.6.3-4.154. PMC 1090429. PMID 21611430. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1090429.
- ^ Lubs, H. A. (1969). "A marker X chromosome". Am. J. Hum. Genet. 21 (3): 231–44. PMC 1706424. PMID 5794013. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1706424.
- ^ Signs of Fragile-X Syndrome – WrongDiagnosis.com
- ^ Haemophilia
- ^ Jordan, Joseph A. Regezi, James J. Sciubba, Richard C.K. (2008). "15". Oral pathology : clinical pathologic correlations (5th ed.). St. Louis, Mo.: Saunders/Elsevier. ISBN 9781416045700. Section on Fragile X syndrome
- ^ a b c Goldstein, Sam; Reynolds, Cecil R. (1999). Handbook of neurodevelopmental and genetic disorders in children. New York: Guilford Press. ISBN 1572304480.
- ^ Holsen, Laura M.; Dalton, Kim M.; Johnstone, Tom; Davidson, Richard J. (2008). "Prefrontal social cognition network dysfunction underlying face encoding and social anxiety in fragile X syndrome". NeuroImage 43 (3): 592–604. doi:10.1016/j.neuroimage.2008.08.009. PMC 2598775. PMID 18778781. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2598775.
- ^ Bourgeois, James A.; Cogswell, Jennifer B.; Hessel, David; Zhang, Lin; Ono, Michele Y.; Tassone, Flora; Farzin, Faraz; Brunberg, James A. et al. (2007). "Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome". General Hospital Psychiatry 29 (4): 349–356. doi:10.1016/j.genhosppsych.2007.03.003. PMID 17591512.
- ^ Shanahan, M.; Roberts, J.; Hatton, D.; Reznick, J.; Goldsmith, H. (2008). "Early temperament and negative reactivity in boys with fragile X syndrome". Journal of Intellectual Disability Research 52 (10): 842–854. doi:10.1111/j.1365-2788.2008.01074.x. PMID 18498331.
- ^ Cornish, Kim; Kogan, Cary S.; Li, Lexin; Turk, Jeremy; Jacquemont, Sebastien; Hagerman, Randi J. (2009). "Lifespan changes in working memory in fragile X premutation males". Brain and Cognition 69 (3): 551–558. doi:10.1016/j.bandc.2008.11.006. PMID 19114290.
- ^ Hall, Scott S.; Burns, David D.; Lightbody, Amy A.; Reiss, Allan L. (2008). "Longitudinal Changes in Intellectual Development in Children with Fragile X Syndrome". Journal of Abnormal Child Psychology 36 (6): 927–939. doi:10.1007/s10802-008-9223-y. PMID 18347972.
- ^ Cornish Kim, Turk Jeremy, Levitas Andrew (2007). "Fragile X Syndrome and Autism: Common Developmental Pathways?". Current Pediatric Reviews 3 (1): 3–4. http://www.ingentaconnect.com/content/ben/cpr/2007/00000003/00000001/art00008.
- ^ a b Hagerman, Randi J., and Paul J. Hagerman. Fragile X syndrome: diagnosis, treatment, and research. 3, illustrated ed. Baltimore, MD: JHU P, 2002.
- ^ a b Bibi G, Malcov M, Yuval Y, Reches, Adi, Ben-Yosef, Dalit, Almog, Beni, Amit, Ami, Azem, Foad (May 2009). "The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis". Fertil. Steril. 94 (3): 869–74. doi:10.1016/j.fertnstert.2009.04.047. PMID 19481741.
- ^ Pietropaolo S, Guilleminot A, Martin B, D'Amato FR, Crusio WE (2011). Cushing, Bruce. ed. "Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice". PLoS ONE 6 (2): e17073. doi:10.1371/journal.pone.0017073. PMC 3043074. PMID 21364941. http://dx.plos.org/10.1371/journal.pone.0017073. Retrieved 2011-04-18.
- ^ Bernardet M, Crusio WE (2006). "Fmr1 KO mice as a possible model of autistic features". The ScientificWorldJournal 6: 1164–76. doi:10.1100/tsw.2006.220. PMID 16998604. http://www.thescientificworld.co.uk/doi/getDoi.asp?doi=10.1100/tsw.2006.220. Retrieved 2011-04-18.
- ^ Mineur YS, Huynh LX, Crusio WE (March 2006). "Social behavior deficits in the Fmr1 mutant mouse". Behavioural Brain Research 168 (1): 172–5. doi:10.1016/j.bbr.2005.11.004. PMID 16343653. http://linkinghub.elsevier.com/retrieve/pii/S0166-4328(05)00471-7. Retrieved 2011-04-18.
- ^ Spencer CM, Alekseyenko O, Hamilton SM, Thomas AM, Serysheva E, Yuva-Paylor LA, Paylor R (February 2011). "Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses". Autism Research 4 (1): 40–56. doi:10.1002/aur.168. PMC 3059810. PMID 21268289. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3059810.
- ^ Spencer CM, Graham DF, Yuva-Paylor LA, Nelson DL, Paylor R (June 2008). "Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene". Behavioral Neuroscience 122 (3): 710–5. doi:10.1037/0735-7044.122.3.710. PMID 18513141. http://content.apa.org/pubmed/bne/122/3/710. Retrieved 2011-04-18.
- ^ Who.int
- ^ Nolin SL, Brown WT, Glicksman A, Houck, Jr., Gargano, Alice D., Sullivan, Amy, Biancalana, Valérie, Bröndum-Nielsen, Karen et al. (2003). "Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles". Am. J. Hum. Genet. 72 (2): 454–64. doi:10.1086/367713. PMC 379237. PMID 12529854. http://linkinghub.elsevier.com/retrieve/pii/S0002-9297(07)60554-0.
- ^ Bassell GJ, Warren ST (2008). "Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function". Neuron 60 (2): 201–14. doi:10.1016/j.neuron.2008.10.004. PMID 18957214.
- ^ Garber KB, Visootsak J, Warren ST (2008). "Fragile X syndrome". Eur J Hum Genet 16 (6): 666–72. doi:10.1038/ejhg.2008.61. PMID 18398441. http://www.nature.com/ejhg/journal/v16/n6/pdf/ejhg200861a.pdf.
- ^ Rueda JR, Ballesteros J, Tejada MI (2009). "Systematic review of pharmacological treatments in fragile X syndrome". BMC Neurol 9: 53. doi:10.1186/1471-2377-9-53. PMC 2770029. PMID 19822023. http://www.biomedcentral.com/1471-2377/9/53.
- ^ Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C. et al. (2009). "Advances in the treatment of fragile X syndrome". Pediatrics 123 (1): 378–90. doi:10.1542/peds.2008-0317. PMC 2888470. PMID 19117905. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2888470.
- ^ Dölen G, Osterweil E, Rao BS, Smith, Gordon B., Auerbach, Benjamin D., Chattarji, Sumantra, Bear, Mark F. (2007). "Correction of fragile X syndrome in mice". Neuron 56 (6): 955–62. doi:10.1016/j.neuron.2007.12.001. PMC 2199268. PMID 18093519. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2199268.
- ^ Dölen G, Carpenter RL, Ocain TD, Bear MF (2010). "Mechanism-based approaches to treating fragile X". Pharmacol Ther 127 (1): 78–93. doi:10.1016/j.pharmthera.2010.02.008. PMID 20303363.
- ^ Highfield R (2007-12-19). "Fragile X study offers hope for autism treatment". Daily Telegraph. http://www.telegraph.co.uk/earth/main.jhtml?xml=/earth/2007/12/19/sciaut119.xml. Retrieved 2007-12-22.
- CDC’s National Center on Birth Defects and Developmental Disabilities
- FraXA.org – The Fragile X Research Foundation
- Fragilex.org.uk – The United Kingdom National Fragile X charity
- FragileX.org The National Fragile X Foundation (US) – Support, Awareness, Education, Research and Advocacy since 1984
- FragileX.org.au – Fragile X Association of Australia – charity – news, forums, support, information, clinics
- The Colorado Fragile X Consortium
- Gene Reviews
- Closely linked to Nicolaides-Baraitser syndrome
Developmental disorders: Pervasive developmental disorders and autism spectrum (F84, 299) Main Diagnoses Related conditions Controversies Diagnostic scales ListsAutism-related topics · Fictional characters · People · Speculated historical figures Pathology: chromosome abnormalities (Q90–Q99 · 758) Autosomal1q21.1 deletion syndrome/1q21.1 duplication syndrome/TAR syndrome (1) · Wolf-Hirschhorn syndrome (4) · Cri du chat/Chromosome 5q deletion syndrome (5) · Williams syndrome (7) · Jacobsen syndrome (11) · Miller–Dieker syndrome/Smith–Magenis syndrome (17) · DiGeorge syndrome (22) · 22q13 deletion syndrome (22)
genomic imprinting (Angelman syndrome/Prader–Willi syndrome (15))Distal 18q-/Proximal 18q-
X/Y linked TranslocationsLymphoidMyeloidOther Other Sex linkage: X-linked disorders X-linked recessive Immune Hematologic Endocrine Metabolicmineral: Menkes disease/Occipital horn syndrome Nervous system
X-Linked mental retardation: Coffin–Lowry syndrome · MASA syndrome · X-linked alpha thalassemia mental retardation syndrome · Siderius X-linked mental retardation syndromeCharcot–Marie–Tooth disease (CMTX2-3) · Pelizaeus–Merzbacher disease · SMAX2
Skin and related tissue Neuromuscular Urologic Bone/tooth No primary system X-linked dominant Non-Mendelian inheritance: anticipation TrinucleotidePolyglutamine (PolyQ), CAGNon-Polyglutamine TetranucleotideCCTG (Myotonic dystrophy type 2) PentanucleotideATTCT (Spinocerebellar ataxia 10) Translation Posttranslational modificationOther
Wikimedia Foundation. 2010.
Look at other dictionaries:
fragile X syndrome — fragile X syndrome. См. синдром Мартина Белл. (Источник: «Англо русский толковый словарь генетических терминов». Арефьев В.А., Лисовенко Л.А., Москва: Изд во ВНИРО, 1995 г.) … Молекулярная биология и генетика. Толковый словарь.
Fragile X syndrome — One of the most common causes of inherited mental retardation and neuropsychiatric disease in human beings, affects as many as one in 2000 males and one in 4000 females. The syndrome is also known as FRAXA (the fragile X chromosome itself) and as … Medical dictionary
fragile-X syndrome — ▪ chromosomal disorder a chromosomal disorder associated with a fragile site on the end of the X chromosome. The major symptom of the syndrome is diminished mental ability, which may range from mild learning impairment to severe… … Universalium
fragile-X syndrome — a major genetic disorder caused by a constriction near the end of the long arm of an X chromosome. The fragile X syndrome is second only to Down s syndrome as a cause of mental retardation. Affected males have unusually high foreheads, unbalanced … Medical dictionary
fragile-X syndrome — a major genetic disorder caused by a constriction near the end of the long arm of an X chromosome. The fragile X syndrome is second only to Down s syndrome as a cause of mental retardation. Affected males have unusually high foreheads, unbalanced … The new mediacal dictionary
fragile x syndrome — noun also fragile x Usage: usually capitalized x Etymology: so called from a fragile (partially gapped) site at band Xq 27 of the X chromosome in those affected with the disorder : an X linked inherited disorder that is caused by a genetic… … Useful english dictionary
fragile X syndrome — noun Date: 1979 an X linked inherited disorder that is characterized especially by moderate to severe mental retardation, by a long face and large ears, and by large testes in males and that often has limited or no effect in heterozygous females… … New Collegiate Dictionary
fragile X syndrome — noun A particular, genetic syndrome, caused by the excessive repetition of a particular trinucleotide … Wiktionary
fragile X syndrome — Most frequent cause of mental retardation. There is an expanded trinucleotide repeat, CGG, in the fra (X) gene … Dictionary of molecular biology
fragile X syndrome — a widespread form of mental retardation caused by a faulty gene on the X chromosome. [1980 85] * * * … Universalium